Z. Liao

发表

Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography.

Rudy Guerra, T. Guerrero, P. Balter, 2008, International journal of radiation oncology, biology, physics.

Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer.

O. Mawlawi, D. Fried, L. Court, 2014, International journal of radiation oncology, biology, physics.

Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer

S. Swisher, T. Buchholz, Steven H. Lin, 2016, Cancer.

Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer.

P. Thall, Steven H. Lin, R. Komaki, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Targeting molecular determinants of tumor chemo-radioresistance.

J. Ajani, Z. Liao, L. Milas, 2005, Seminars in oncology.

Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer.

George Starkschall, Karl Prado, Tinsu Pan, 2007, International journal of radiation oncology, biology, physics.

Endoscopic Ultrasound after Preoperative Chemoradiation Can Help Identify Patients Who Benefit Maximally after Surgical Esophageal Resection

J. Ajani, J. Roth, S. Swisher, 2004, American Journal of Gastroenterology.

Anatomic change over the course of treatment for non–small cell lung cancer patients and its impact on intensity-modulated radiation therapy and passive-scattering proton therapy deliveries

Xiaodong Zhang, Jinzhong Yang, Z. Liao, 2020, Radiation Oncology.

NTCP Models for Severe Radiation Induced Dermatitis After IMRT or Proton Therapy for Thoracic Cancer Patients

R. Mohan, M. Durante, Z. Liao, 2020, Frontiers in Oncology.

Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-small Cell Lung Cancer: A Phase II Randomized Trial.

Joe Y. Chang, Steven H. Lin, C. Cleeland, 2020, International journal of radiation oncology, biology, physics.

Survival Patterns for Patients with Resected N2 Non–Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach

Z. Liao, Pei Yang, Ting Xu, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

4D Proton treatment planning strategy for mobile lung tumors.

Joe Y. Chang, He Wang, Lei Dong, 2007, International journal of radiation oncology, biology, physics.

Potential Use of (18)F-fluorodeoxyglucose Positron Emission Tomography-Based Quantitative Imaging Features for Guiding Dose Escalation in Stage III Non-Small Cell Lung Cancer.

O. Mawlawi, X. Fave, Lifei Zhang, 2016, International journal of radiation oncology, biology, physics.

Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors.

Osama Mawlawi, Shouhao Zhou, Zhongxing Liao, 2016, Radiology.

Analysis of radiation pneumonitis risk using a generalized Lyman model.

Radhe Mohan, Zhongxing Liao, Xiong Wei, 2008, International journal of radiation oncology, biology, physics.

Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.

Daniel Gomez, Zhongxing Liao, Li-E Wang, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.

Radhe Mohan, Zhongxing Liao, Ting Xu, 2013, International journal of radiation oncology, biology, physics.

Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.

Radhe Mohan, Daniel Gomez, Zhongxing Liao, 2013, International journal of radiation oncology, biology, physics.

Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer

Peter Balter, Radhe Mohan, Daniel Gomez, 2017, Scientific Reports.

Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.

Thomas Guerrero, Zhongxing Liao, Richard Castillo, 2013, International journal of radiation oncology, biology, physics.

Radiogenomics: radiobiology enters the era of big data and team science.

Andre Dekker, Michael Baumann, Karin Haustermans, 2014, International journal of radiation oncology, biology, physics.

Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiation therapy.

Laurence Court, Lei Dong, Yongbin Zhang, 2013, Practical radiation oncology.

Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function.

G Starkschall, R. Munden, K. Forster, 2001, International journal of radiation oncology, biology, physics.

Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription.

George Starkschall, Steven J Frank, Zhongxing Liao, 2003, International journal of radiation oncology, biology, physics.

Attenuation correction of PET images with respiration-averaged CT images in PET/CT.

R. Castillo, R. Mohan, S. Nehmeh, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Attenuation correction of PET cardiac data with low-dose average CT in PET/CT.

Tinsu Pan, Osama Mawlawi, Zhongxing Liao, 2006, Medical physics.

Image-guided radiation therapy for non-small cell lung cancer.

George Starkschall, Peter Balter, Radhe Mohan, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer.

Radhe Mohan, Joe Y. Chang, Zhongxing Liao, 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.

Radhe Mohan, Edward S. Kim, Xiong Wei, 2010, International journal of radiation oncology, biology, physics.

Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer.

Peter Balter, Joe Y. Chang, Lei Dong, 2011, International journal of radiation oncology, biology, physics.

SU‐E‐T‐784: Automated VMAT Treatment Planning for Stage III Lung Cancer: How Does It Compare with IMRT?

Joe Y. Chang, Xiaodong Zhang, P. Balter, 2011 .

Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC.

Joe Y. Chang, Xiaodong Zhang, Steven H. Lin, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Proton therapy for locally advanced non-small cell lung cancer.

Z. Liao, O. Gjyshi, 2020, The British journal of radiology.

Reirradiation of thoracic cancers with intensity modulated proton therapy.

Joe Y. Chang, Xiaodong Zhang, D. Gomez, 2018, Practical radiation oncology.

Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series.

Xiaodong Zhang, D. Gomez, X. Zhu, 2015, Practical radiation oncology.

Patterns of Cardiac Perfusion Abnormalities After Chemoradiotherapy in Patients with Lung Cancer

Joe Y. Chang, R. Komaki, Z. Liao, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Survey on use of postmastectomy radiotherapy for breast cancer in China.

Z. Liao, Zi-hao Yu, Yexiong Li, 2006, International journal of radiation oncology, biology, physics.

Prescribing Radiation Dose to Lung Cancer Patients Based on Personalized Toxicity Estimates

Cody A. Wages, M. Martel, Z. Liao, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II trial of concurrent atezolizumab with chemoradiation in unresectable non-small cell lung cancer.

Joe Y. Chang, P. Thall, D. Gomez, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotype in lymphocytes.

R. Mohan, J. Welsh, Steven H. Lin, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis.

Z. Liao, Haiquan Chen, A. Chi, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.

Joe Y. Chang, D. Gomez, P. Balter, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long‐Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Joe Y. Chang, D. Gomez, P. Balter, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.

Joe Y. Chang, T. Guerrero, K. Forster, 2007, International journal of radiation oncology, biology, physics.

Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

K. Forster, J. Roth, S. Swisher, 2007, The Annals of thoracic surgery.

Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma

D. Gomez, R. Komaki, Z. Liao, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combinations of Taxanes and Ionizing Radiation

K. Ang, Z. Liao, L. Milas, 2006 .

Impact of intra-fractional motion on dose distributions in lung IMRT

He Wang, R. Mohan, Jinzhong Yang, 2020, Journal of Radiotherapy in Practice.

Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study

Tinsu Pan, Qiuling Shi, Charles S Cleeland, 2018, Quality of Life Research.

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

Hongliang Liu, Li-E. Wang, Q. Wei, 2016, Clinical lung cancer.

A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2015, Journal of gastrointestinal oncology.

Comparing Proton Beam to Intensity Modulated Radiation Therapy Planning in Esophageal Cancer

Steven H. Lin, Z. Liao, J. Cox, 2015 .

Factors Associated with Local–Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer

J. Ajani, J. Welsh, S. Swisher, 2013, Annals of Surgical Oncology.

Esophageal cancer dose escalation using a simultaneous integrated boost technique.

J. Ajani, D. Gomez, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.

J. Ajani, S. Swisher, T. Buchholz, 2009, International journal of radiation oncology, biology, physics.

Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.

J. Ajani, J. Roth, Q. Wei, 2006, International journal of radiation oncology, biology, physics.

Proposed Revision of the Esophageal Cancer Staging System to Accommodate Pathologic Response (pP) Following Preoperative Chemoradiation (CRT)

K. Hunt, J. Ajani, L. Chirieac, 2005, Annals of surgery.

Evaluation of conventional radiotherapy vs. conformal radiotherapy in the treatment of non-small-cell lung cancer after surgical resection

Z. Liao, J. Cox, P. Allen, 2007 .

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.

Joe Y. Chang, T. Guerrero, J. Roth, 2004, International journal of radiation oncology, biology, physics.

Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer.

R. Komaki, Z. Liao, L. Milas, 2004, Seminars in oncology.

Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.

Joe Y. Chang, D. Gomez, Z. Liao, 2015, International journal of radiation oncology, biology, physics.

Intra-thoracic tumor motion estimation from CT imaging using 3D optical flow method

T. Guerrero, Z. Liao, Tzung-Chi Huang, 2004 .

SNPs in the TGF-β Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non–Small-Cell Lung Cancer

Z. Liao, Kai Qin, Xianglin Yuan, 2012, PloS one.

Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

M. Martel, Li-E. Wang, Q. Wei, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy

Ping Wang, Steven H. Lin, Z. Liao, 2019, Clinical and translational radiation oncology.

Association between Systemic Chemotherapy before Chemoradiation and Increased Risk of Treatment-Related Pneumonitis in Esophageal Cancer Patients Treated with Definitive Chemoradiotherapy

R. Mohan, J. Ajani, S. Swisher, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

Joe Y. Chang, K. Ahrar, D. Gomez, 2018, JAMA network open.

Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma

J. Ajani, Steven H. Lin, R. Komaki, 2017, Annals of surgery.

Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non–small‐cell Lung Cancer

D. Gomez, J. Welsh, Z. Liao, 2017, Clinical lung cancer.

Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection

Z. Liao, Jianji Pan, L. Liao, 2014, BMC Surgery.

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

D. Gomez, S. Swisher, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.

Z. Liao, Jianji Pan, Ming Chen, 2013, International journal of radiation oncology, biology, physics.

Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non–Small Cell Lung Cancer Using Conditional Survival Analysis

D. Gomez, R. Komaki, Z. Liao, 2015, American journal of clinical oncology.

The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care.

Aashish K Shah, A. Garden, D. Gomez, 2019, International journal of radiation oncology, biology, physics.

Effects of respiration-averaged CT on PET/CT quantification and its potential impact on GTV delineation

T. Pan, O. Mawlawi, P. Chi, 2014 .

Strategies to Flatten the Curve during the COVID-19 Pandemic in Radiation Oncology: Experience from a Large Tertiary Cancer Center

W. Woodward, A. Koong, M. McAleer, 2020, Advances in Radiation Oncology.

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.

Z. Liao, S. Tucker, L. Fuller, 1998, International journal of radiation oncology, biology, physics.

Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center

W. Woodward, A. Koong, M. McAleer, 2020, Advances in radiation oncology.

Prospective Exploratory Analysis of Cardiac Biomarkers and Electrocardiogram Abnormalities in Patients Receiving Thoracic Radiation Therapy with High-Dose Heart Exposure

Joe Y. Chang, D. Gomez, J. Welsh, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment

Steven H. Lin, Z. Liao, J. Abe, 2022, Current Oncology Reports.

Modern Radiotherapy and Risk of Cardiotoxicity

Steven H. Lin, Z. Liao, J. Abe, 2020, Chemotherapy.

Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer.

J. Ajani, J. Roth, S. Swisher, 2010, The Annals of thoracic surgery.

COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer

Z. Liao, L. Milas, 2004, Expert review of anticancer therapy.

Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2018, International journal of radiation oncology, biology, physics.

Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

J. Lee, D. Gomez, J. Welsh, 2017, International journal of radiation oncology, biology, physics.

7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial

Joe Y. Chang, J. Roth, D. Gomez, 2017, Cancer.

Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk Fields.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2020, Clinical lung cancer.

Radiotherapy in malignant pleural mesothelioma.

M. McAleer, Z. Liao, A. Tsao, 2009, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.

K. Forster, G. Starkschall, C. Stevens, 2003, International journal of radiation oncology, biology, physics.

Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine

W. Oyen, Z. Liao, M. Ginsberg, 2022, JCO global oncology.

Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses

A. Koong, Z. Liao, J. Herman, 2019, Acta oncologica.

Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.

D. Gomez, J. Welsh, R. Komaki, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non–Small‐Cell Lung Cancer After Definitive Radiation Therapy

D. Gomez, J. Welsh, Z. Liao, 2018, Clinical lung cancer.

Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma

J. Ajani, S. Swisher, Z. Liao, 2005, Cancer.

Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19☆

Steven H. Lin, A. Koong, M. McAleer, 2020, Radiotherapy and Oncology.

Outcomes and patterns of failure in bronchial carcinoid tumors.

C. Stevens, R. Komaki, Z. Liao, 2003, International journal of radiation oncology, biology, physics.

Radiation pneumonitis: local dose versus [18F]-fluorodeoxyglucose uptake response in irradiated lung.

V. Johnson, T. Guerrero, T. Pan, 2007, International journal of radiation oncology, biology, physics.

Cetuximab in combination with chemoradiotherapy in Chinese patients with non-resectable, locally advanced esophageal squamous cell carcinoma: a prospective, multicenter phase II trail.

Z. Liao, Jinming Yu, Jian-hua Wang, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

4D CT-based Treatment Planning for Intensity-Modulated Radiation Therapy and Proton Therapy for Distal Esophagus Cancer

T. Guerrero, R. Mohan, Xiaodong Zhang, 2008 .

Patterns and correlates of treatment failure in relation to isodose distribution in non-small cell lung cancer: An analysis of 1522 patients in the modern era.

Joe Y. Chang, K. Hess, Z. Liao, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer

Joe Y. Chang, A. Garden, C. Fuller, 2020, Head & neck.

Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure.

D. Gomez, J. Welsh, P. Balter, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

2485 : Preliminary Report of Image-Guided Hypofractionated Stereotactic Body Radiotherapy to Treat Patients With Medically Inoperable Stage I or Isolated Peripheral Lung Recurrent Non-Small Cell Lung Cancer

T. Guerrero, J. Roth, P. Balter, 2006 .

The relationship between local dose and loss of function for irradiated lung.

K. Forster, G. Starkschall, C. Stevens, 2003, International journal of radiation oncology, biology, physics.

Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy

Q. Wei, D. Gomez, R. Komaki, 2012, Cancer.

Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

Joe Y. Chang, D. Gomez, Steven H. Lin, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer.

R. Mohan, D. Gomez, Z. Liao, 2019, International journal of radiation oncology, biology, physics.

lLong-Term Outcomes after Proton Therapy, with Concurrent Chemotherapy, for Stage II-III Inoperable Non-Small Cell Lung Cancer

Joe Y. Chang, Z. Liao, L. Levy, 2016 .

Abstract2466: Improving Tumor Localization and Standard Uptake Value Quantitation of Non-Small Cell Lung Cancer and Esophageal Cancer Patients by New Respiration-Averaged CT in PET/CT Imaging

R. Mohan, T. Pan, O. Mawlawi, 2006 .

O-152 Analysis of acute toxicity results of intensity modulated radiationtherapy (IMRT) in the treatment of non-small cell lung cancer (NSCLC)

Joe Y. Chang, T. Guerrero, C. Stevens, 2005 .

Exclusion of Elective Nodal Irradiation Does Not Decrease Local Regional Control of Non-Small Cell Lung Cancer

T. Guerrero, C. Stevens, R. Komaki, 2005 .

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy

Q. Wei, R. Komaki, Z. Liao, 2010, BMC Cancer.

Lung cancer

Joe Y. Chang, Xiaodong Zhang, Steven H. Lin, 2019, Proton Therapy.

Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer

D. Gomez, Z. Liao, S. Hahn, 2017, Oncotarget.

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.

Joe Y. Chang, T. Guerrero, R. Herbst, 2007, International journal of radiation oncology, biology, physics.

High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non–Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy

Joe Y. Chang, M. Spitz, Xifeng Wu, 2005, Clinical Cancer Research.

Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes.

D. Gomez, J. Welsh, R. Komaki, 2014, International journal of radiation oncology, biology, physics.

IClinicalTrial ofThoracic Radiotherapy and Concurrent Celecoxib for Patientswith Unfavorable Performance Status Inoperable / Unresectable Non ^ Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005 .

Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.

R. Komaki, Z. Liao, L. Milas, 2003, Clinical lung cancer.

Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2020, International journal of radiation oncology, biology, physics.

Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non‐small cell lung cancer patients treated with definitive radiotherapy

Q. Wei, Z. Liao, J. Welsh, 2012, Cancer science.

Vivekananda Yoga Program for Patients With Advanced Lung Cancer and Their Family Caregivers

Z. Liao, C. Carmack, L. Cohen, 2015, Integrative cancer therapies.

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma

Steven H. Lin, Z. Liao, C. Hallemeier, 2019, Advances in radiation oncology.

Patterns of Failure, Toxicity, and Survival after Extrapleural Pneumonectomy and Hemithoracic Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma

D. Gomez, R. Komaki, Z. Liao, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.

K. Ang, Z. Liao, L. Milas, 2004, International journal of radiation oncology, biology, physics.

Role of Cyclooxygenase-2 (COX-2) and Its Inhibition in Tumor Biology and Radiotherapy

K. Ang, Z. Liao, L. Milas, 2003 .

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

Steven H. Lin, R. Komaki, Z. Liao, 2020, Journal of Translational Medicine.

Cyclo-Oxygenase-2 and its Inhibition in Cancer

Z. Liao, L. Milas, K. Mason, 2012, Drugs.

Cyclo-Oxygenase-2 Enzyme and Its Inhibition in Tumor Growth and Therapy

Z. Liao, L. Milas, K. Mason, 2005 .

Combination of a COX-2 Inhibitor With Radiotherapy or Radiochemotherapy in the Treatment of Thoracic Cancer

C. Stevens, Z. Liao, J. Cox, 2003, American journal of clinical oncology.

Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.

S. Singletary, K. Hunt, A. Buzdar, 2000, International journal of radiation oncology, biology, physics.

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy

Joe Y. Chang, Xiaodong Zhang, Z. Liao, 2022, Scientific Reports.

Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, Practical radiation oncology.

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

Peter Balter, Stephen G Swisher, Joe Y. Chang, 2012, Radiation oncology.

Stereotactic Body Radiation Therapy Results in Promising Local Control in Patients with Recurrent or Secondary Lung Parenchyma Cancer after Definitive Conventional Thoracic Radiotherapy

P. Balter, R. Komaki, Z. Liao, 2009 .

Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.

D. Gomez, Z. Liao, L. Levy, 2013, International journal of radiation oncology, biology, physics.

Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non-Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab.

Steven H. Lin, Z. Liao, J. Heymach, 2020, Clinical lung cancer.

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.

J. Ajani, J. Gu, Xifeng Wu, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells.

Z. Liao, L. Milas, U. Raju, 2011, Anticancer research.

Retrospective Planning Study of Patients with Superior Sulcus Tumours Comparing Pencil Beam Scanning Protons to Volumetric-Modulated Arc Therapy

Z. Liao, G. Royle, S. Gulliford, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy

M. Zhang, Steven H. Lin, R. Komaki, 2017, Clinical Cancer Research.

Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer.

D. Gomez, R. Komaki, Z. Liao, 2014, International journal of radiation oncology, biology, physics.

Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy

Q. Wei, D. Gomez, Z. Liao, 2011, PloS one.

Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer.

G. Starkschall, C. Stevens, R. Komaki, 2003, International journal of radiation oncology, biology, physics.

HighMutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage IIINon^Small Cell Lung Cancer Treatedwith Radiotherapy and Chemotherapy

Joe Y. Chang, M. Spitz, C. Stevens, 2005 .

Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic

Benjamin D. Smith, A. Koong, Z. Liao, 2021, Advances in Radiation Oncology.

Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer.

Joe Y. Chang, Steven H. Lin, Z. Liao, 2021, Clinical lung cancer.

Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care.

Joe Y. Chang, D. Gomez, A. Koong, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy

Steven H. Lin, A. Koong, Z. Liao, 2022, International journal of particle therapy.

Single Nucleotide Polymorphism at rs1982073:T869C of the TGF (cid:1) 1 Gene Is Associated With the Risk of Radiation Pneumonitis in Patients With Non–Small-Cell Lung Cancer Treated With Deﬁnitive Radiotherapy

Q. Wei, Z. Liao, Zhensheng Liu, 2009 .

Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC

R. Mohan, Steven H. Lin, Z. Liao, 2022, JTO Clinical and Research Reports.

Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

C. Fuller, J. Welsh, R. Komaki, 2019, JAMA oncology.

Influence of Preoperative Radiation Field on Postoperative Leak Rates in Esophageal Cancer Patients after Trimodality Therapy

S. Swisher, Steven H. Lin, R. Komaki, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

Joe Y. Chang, C. Fuller, J. Welsh, 2020, JAMA network open.

Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.

Joe Y. Chang, E. Bruera, S. Shete, 2022, The Lancet. Oncology.

Outcomes and toxicity following high-dose radiation therapy in 15 fractions for non-small cell lung cancer.

D. Gomez, Steven H. Lin, Z. Liao, 2017, Practical radiation oncology.

The effects of radiation therapy, chemotherapy and the radioprotector amifostine on the diffusion capacity of patients with non-small cell lung cancer (NSCLC)

G. Starkschall, C. Stevens, R. Komaki, 2001 .

Joe Y. Chang, Steven H. Lin, Z. Liao, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Toxicity and Survival after Intensity-Modulated Proton Therapy (IMPT) versus Passive Scattering Proton Therapy (PSPT) for Non-Small Cell Lung Cancer.

Joe Y. Chang, Steven H. Lin, X. Zhu, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Proton theraPy sPecial feature: review article Proton therapy for locally advanced non- small cell lung cancer

Z. Liao, O. Gjyshi, 2020 .

A Mindfulness-Based Intervention as a Supportive Care Strategy for Patients with Metastatic Non-Small Cell Lung Cancer and Their Spouses: Results of a Three-Arm Pilot Randomized Controlled Trial

Z. Liao, C. Carmack, L. Cohen, 2020 .

International outreach: what is the responsibility of ASTRO and the major international radiation oncology societies?

Z. Liao, J. Palta, N. Mayr, 2014, International journal of radiation oncology, biology, physics.

A phase III multicenter randomized clinical trial of 60 Gy vs 50 Gy radiation dose in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma.

Z. Liao, Zongwen Sun, Jiong Cai, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

MA08.01 Analysis of PD-L1 Expression on Circulating Stromal and Tumor Cells in Lung Cancer Patients Treated with Chemoradiation Therapy and Atezolizumab

Z. Liao, J. Heymach, A. Tsao, 2019, Journal of Thoracic Oncology.

Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.

R. Mohan, D. Gomez, R. Komaki, 2018, International journal of radiation oncology, biology, physics.

18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma

Steven H. Lin, R. Komaki, Z. Liao, 2017, The Journal of Nuclear Medicine.

Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.

Z. Liao, Jianji Pan, Xiong-wei Zheng, 2012, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer.

Helen H Liu, J. Ajani, S. Swisher, 2006, World journal of gastroenterology.

Radiation therapy induces immunosenescence mediated by p90RSK

E. Amir, Steven H. Lin, Z. Liao, 2022, Frontiers in Cardiovascular Medicine.

The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer

R. Mohan, T. Solberg, C. Simone, 2017, Front. Oncol..

Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.

R. Mohan, M. Martel, Jinzhong Yang, 2017, International journal of radiation oncology, biology, physics.

Lung Perfusion Imaging Can Risk Stratify Lung Cancer Patients for the Development of Pulmonary Complications after Chemoradiation

Joe Y. Chang, Katsuhiro Kobayashi, R. Komaki, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.

R. Mohan, Xiaodong Zhang, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Locally Advanced Non-Small Cell Lung Cancer and Small Cell Lung Cancer

D. Gomez, P. Balter, Z. Liao, 2014 .

Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.

R. Mohan, M. Martel, P. Balter, 2012, International journal of radiation oncology, biology, physics.

Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial.

R. Mohan, Z. Liao, H. Paganetti, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Preliminary Report of Radiation Pneumonitis (RP) in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Intensity Modulated Radiotherapy (IMRT) and Concurrent Chemotherapy (ConChT)

R. Mohan, R. Komaki, Z. Liao, 2005 .

SU‐FF‐T‐380: Dose Mass Histogram and Its Application for 4D Treatment Planning

Lei Dong, R. Mohan, R. Komaki, 2005 .

Technical Note: A Monte Carlo study of magnetic-field-induced radiation dose effects in mice.

J. Hazle, M. Guindani, L. Court, 2015, Medical physics.

Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience

Joe Y. Chang, T. Guerrero, J. Ajani, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Gemcitabine (G) with concurrent chest radiation (XRT) followed by consolidation chemotherapy with gemcitabine plus cisplatin (CDDP): A phase I trial for patients with stage III non-small cell lung cancer (NSCLC)

F. Khuri, W. Hong, R. Herbst, 2000 .

Four-dimensional CT- and On-board Volumetric Image-guided Stereotactic Ablative Radiotherapy (SABR) for Stage I Non-small Cell Lung Cancer

J. Roth, S. Swisher, P. Balter, 2011 .

An open label, multicenter clinical study of cetuximab combined with concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: Preliminary results of a phase II trial.

Z. Liao, Jiang Yu, M. Ye, 2010 .

Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy.

D. Gomez, S. Swisher, G. Rao, 2014, International journal of radiation oncology, biology, physics.

GLOTTIC CANCER TREATED WITH DEFINITIVE RADIOTHERAPY ALONE : EXPERIENCE OF THE CANCER HOSPITAL OF PEKING UNION MEDICAL COLLEGE AND THE CHINESE ACADEMY OF MEDICAL SCIENCES

Z. Liao, J. Jin, Li Gao, 2002 .

Couple‐based Tibetan yoga program for lung cancer patients and their caregivers

Z. Liao, C. Carmack, L. Cohen, 2015, Psycho-oncology.

Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak

Z. Liao, A. Salem, Q. Pang, 2020, Lung Cancer.

Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis.

D. Gomez, S. Swisher, Steven H. Lin, 2012, International journal of radiation oncology, biology, physics.

A comparison of two methodologies for radiotherapy treatment plan optimization and QA for clinical trials

R. Mohan, Z. Liao, F. Yin, 2021, Journal of applied clinical medical physics.

Extrapleural pneumonectomy followed by IMRT: Results of a phase I/II study

T. Guerrero, K. Forster, C. Stevens, 2005 .

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017, JAMA oncology.

Poster PresentationThe 5-Year Outcome for Patients Diagnosed With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Concurrent Chemotherapy and Proton Beam Therapy: Locally Advanced Non-Small Cell Lung Cancer

D. Gomez, R. Komaki, Z. Liao, 2014 .

Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation.

Joe Y. Chang, D. Gomez, J. Welsh, 2015, Clinical lung cancer.

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

IMRT Versus Passively Scattered Proton Therapy (PSPT) for Locally Advanced NSCLC -- Impact of Changing Techniques and Technologies Over the Course of a Randomized Trial

R. Mohan, R. Komaki, Z. Liao, 2012 .

Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial.

Joe Y. Chang, Steven H. Lin, Z. Liao, 2022, Lung cancer.

Significantly Reduced Normal Tissue Dose with Proton Radiotherapy Compared with 3D-CRT or IMRT in Stage I or Stage III Non-Small Cell Lung Cancer

R. Mohan, R. Komaki, Z. Liao, 2005 .

PD5-1-8: 4D CT imaging impacts lung volume definitions and dose-volume relationships in radiation treatment of non-small cell lung cancer

Joe Y. Chang, Lei Dong, R. Mohan, 2007 .

Personalized mid-course FDG-PET based adaptive treatment planning for non-small cell lung cancer using machine learning and optimization

T. Bortfeld, R. Mohan, Z. Liao, 2022, Physics in medicine and biology.

Modulators of radiation-induced cardiopulmonary toxicities for non-small cell lung cancer: Integrated cytokines, single nucleotide variants, and HBP systems imaging

Z. Liao, Tomio Inoue, David Yang, 2022, Frontiers in Oncology.

The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression

J. Ajani, Steven H. Lin, Z. Liao, 2020, Cell Research.

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.

R. Herbst, C. Stevens, R. Komaki, 2004, International journal of radiation oncology, biology, physics.

Chemoradiotherapy: Emerging treatment improvement strategies

K. Ang, Z. Liao, L. Milas, 2003, Head & neck.

Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer.

Q. Wei, D. Gomez, J. Welsh, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis

S. Hassenbusch, R. Komaki, Z. Liao, 2006, Cancer.

The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression

J. Ajani, Steven H. Lin, Z. Liao, 2020, Cell Research.

Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer.

R. Mohan, M. Durante, Z. Liao, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radioprotectors and Chemoprotectors in the Management of Lung Cancer

R. Komaki, Z. Liao, J. Cox, 2011 .

Radiation-Induced Esophagitis in Non-Small-Cell Lung Cancer Patients: Voxel-Based Analysis and NTCP Modeling

R. Mohan, Z. Liao, S. Monti, 2022, Cancers.

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Thomas Guerrero, Radhe Mohan, Joe Y. Chang, 2004, International journal of radiation oncology, biology, physics.

Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.

Wei Liu, Joe Y. Chang, Martin Bues, 2016, International journal of radiation oncology, biology, physics.

ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Hongliang Liu, Q. Wei, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

Daniel Gomez, Zhongxing Liao, Li-E Wang, 2011, International journal of radiation oncology, biology, physics.

Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).

Zhongxing Liao, Xiong Wei, Helen H Liu, 2005, International journal of radiation oncology, biology, physics.

Risk Prediction for Locoregional Recurrence in Epidermal Growth Factor Receptor-Mutant Stage III-pN2 Lung Adenocarcinoma after Complete Resection: A Multi-center Retrospective Study

J. Yun, W. Liang, Steven H. Lin, 2020, Journal of Cancer.

Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.

R. Mohan, Hongliang Liu, Q. Wei, 2014, European journal of cancer.

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

P. A. Futreal, X. Yi, K. Ye, 2020, Clinical Cancer Research.

Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

P. A. Futreal, X. Yi, I. Wistuba, 2018, Nature Communications.

Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.

Radhe Mohan, Lei Dong, Zhongxing Liao, 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer

Ash A. Alizadeh, K. Ramchandran, J. Chabon, 2020, Nature Cancer.

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.

Radhe Mohan, Stephen M Hahn, John V Heymach, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.

K. Forster, G. Starkschall, C. Stevens, 2003, International journal of radiation oncology, biology, physics.

The clinical implications of myocardial perfusion abnormalities in patients with esophageal or lung cancer after chemoradiation therapy

M. McAleer, Z. Liao, S. Yusuf, 2009, The International Journal of Cardiovascular Imaging.

Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review.

Z. Liao, Q. Wei, M. Yin, 2009, American journal of translational research.

Molecular Biology of Lung Cancer

I. Wistuba, Z. Liao, L. Milas, 2006 .

Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.

J. Ajani, S. Swisher, Tsung-Teh Wu, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Road Less Traveled: Should We Omit Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer?

Z. Liao, T. Sio, J. Yue, 2018, Clinical lung cancer.

Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

Helen H Liu, J. Ajani, S. Swisher, 2006, International journal of radiation oncology, biology, physics.

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.

Joe Y. Chang, Edward S. Kim, P. Brown, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Z. Liao, S. Tucker, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.

Z. Liao, J. Masferrer, L. Milas, 2003, Oncology.

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications.

Zhongxing Liao, R. Komaki, Z. Liao, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Translational Research and Immunotherapy in Lung Cancer

D. Gomez, J. Welsh, Z. Liao, 2016 .

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

R. Mohan, M. Martel, R. Komaki, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC

Radhe Mohan, Ying Xiao, Zhongxing Liao, 2016, Radiation Oncology.

Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest

Joe Y. Chang, T. Guerrero, K. Forster, 2003, Cancer journal.

Radiochemotherapy of esophageal cancer.

Z. Liao, J. Cox, R. Komaki, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pretherapy nuclear factor-κB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma

J. Ajani, Tsung-Teh Wu, Z. Liao, 2006, Molecular Cancer Therapeutics.

The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation

J. Ajani, S. Swisher, Tsung-Teh Wu, 2006, Cancer.

Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.

J. Ajani, J. Roth, S. Swisher, 2004, International journal of radiation oncology, biology, physics.

Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus

J. Ajani, J. Roth, S. Swisher, 2005, International journal of gastrointestinal cancer.

Failure patterns in patients with esophageal cancer treated with definitive chemoradiation

J. Ajani, R. Komaki, Z. Liao, 2012, Cancer.

Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer.

Joe Y. Chang, A. Garg, T. Guerrero, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.

Joe Y. Chang, J. Roth, J. Welsh, 2021, The Lancet. Oncology.

Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.

Daniel Gomez, Lei Dong, Zhongxing Liao, 2011, International journal of radiation oncology, biology, physics.

Abstract 4745: Circulating cytokine levels predictive of Grade≥3 radiation pneumonitis: Preliminary secondary analysis of a randomized controlled trial of definitive chemoradiation in locally advanced NSCLC

Steven H. Lin, R. Komaki, Z. Liao, 2017 .

Preoperative Chemo-Radiation-Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated Computed Tomographic-Positron Emission Tomographic Imaging

R. Munden, J. Ajani, S. Swisher, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas MD Anderson Cancer Center experience

J. Ajani, S. Swisher, Steven H. Lin, 2017, Cancer.

Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non–Small Cell Lung Cancer after Definitive Radiotherapy

Hongliang Liu, Q. Wei, D. Gomez, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Combinations of Radiation Therapy and Chemotherapy for Non-Small Cell and Small-Cell Lung Carcinoma

D. Gomez, R. Komaki, Z. Liao, 2014 .

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.

P. Thall, J. Ajani, J. Roth, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography

J. Ajani, S. Swisher, Z. Liao, 2010, Cancer.

The Standardized Uptake Value of 18-Fluorodeoxyglucose Positron Emission Tomography after Chemoradiation and Clinical Outcome in Patients with Localized Gastroesophageal Carcinoma

J. Ajani, S. Swisher, Z. Liao, 2010, Oncology.

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

J. Ajani, S. Swisher, Z. Liao, 2009, Cancer.

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.

J. Ajani, J. Bradley, R. Komaki, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer.

C. Stevens, R. Komaki, Z. Liao, 2002, International journal of radiation oncology, biology, physics.

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival

Joe Y. Chang, J. Lee, S. Swisher, 2023, JCO precision oncology.

Whole Brain Radiotherapy With and Without Concurrent Erlotinib in NSCLC with Brain Metastases: a multicentre, open-label, randomized, controlled phase 3 Trial.

D. Carbone, Z. Liao, Rongqing Li, 2020, Neuro-oncology.

Metabolic Responses to Metformin in Inoperable Early-stage Non–Small Cell Lung Cancer Treated With Stereotactic Radiotherapy

Joe Y. Chang, T. Guerrero, Steven H. Lin, 2020, American Journal of Clinical Oncology.

Multimodality Treatment of Pancreatic Cancer With Liver Metastases Using Chemotherapy, Radiation Therapy, and/or Chinese Herbal Medicine

Zhongxing Liao, Zhiqiang Meng, Peng Wang, 2011, Pancreas.

Blood-based biomarkers for precision medicine in lung cancer: precision radiation therapy.

J. She, Z. Liao, D. de Ruysscher, 2017, Translational lung cancer research.

Evaluation of Treatment-Related Toxicity and Clinical Outcome in Lung Cancer Treated by Image-Guided Radiotherapy and Chemotherapy

Helen H Liu, Z. Liao, 2007 .

Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy

J. Ajani, J. Roth, S. Swisher, 2006, Cancer.

Epidermal growth factor receptor as a target to improve treatment of lung cancer.

K. Ang, R. Komaki, Z. Liao, 2004, Clinical lung cancer.

The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis

Laurence E. Court, Zhongxing Liao, Arvind Rao, 2018, Medical physics.

Automated Quality Assurance of OAR Contouring for Lung Cancer Based on Segmentation With Deep Active Learning

Kuo Men, Ying Xiao, Huaizhi Geng, 2020, Frontiers in Oncology.

Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancer.

Z. Liao, Jinming Yu, W. Deng, 2018, Cancer letters.

Radiotherapy clinical trial enrollment during the COVID-19 pandemic

Benjamin D. Smith, K. Hoffman, A. Koong, 2020, Acta oncologica.

Syndrome of inappropriate antidiuretic hormone secretion in a woman with small cell lung cancer

Z. Liao, J. Bruzzi, Shulian Wang, 2005 .

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

X. Yi, Z. Liao, Bing-he Xu, 2020, International journal of cancer.

Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?

Joe Y. Chang, S. McGovern, M. McAleer, 2009, Cancer.

Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation.

Jinzhong Yang, Z. Liao, S. Tucker, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer.

Steven H. Lin, R. Komaki, Z. Liao, 2017, International journal of radiation oncology, biology, physics.

Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?

E. Yorke, M. Martel, X. Li, 2018, International journal of radiation oncology, biology, physics.

Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients with Early-Stage Non-Small Cell Lung Cancer.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Development and application of an elastic net logistic regression model to investigate the impact of cardiac substructure dose on radiation-induced pericardial effusion in patients with NSCLC

Jinzhong Yang, L. Court, D. Gomez, 2020, Acta oncologica.

Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer.

G. Gladish, Steven H. Lin, Z. Liao, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.

J. Roth, S. Swisher, Z. Liao, 2020, Clinical lung cancer.

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

Joe Y. Chang, P. Thall, Steven H. Lin, 2020 .

Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer.

Zhongxing Liao, Pierre Blanchard, Z. Liao, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Automatic segmentation of cardiac substructures from noncontrast CT images: accurate enough for dosimetric analysis?

Daniel Gomez, Zhongxing Liao, Laurence E Court, 2018, Acta oncologica.

Trends and Outcomes of Proton Radiation Therapy Use for Non–Small Cell Lung Cancer

Joe Y. Chang, D. Gomez, Steven H. Lin, 2018, International journal of particle therapy.

Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?

Steven H. Lin, J. Bradley, Z. Liao, 2018, Seminars in radiation oncology.

Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy.

D. Gomez, Y. Liu, R. Komaki, 2018, International journal of radiation oncology, biology, physics.

Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer

Z. Liao, Ming Chen, W. Deng, 2017, Scientific Reports.

Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.

D. Gomez, Z. Liao, J. Huo, 2017, International journal of radiation oncology, biology, physics.

Cardiac atlas development and validation for automatic segmentation of cardiac substructures.

Tinsu Pan, Zhongxing Liao, Jinzhong Yang, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer.

Joe Y. Chang, D. Gomez, R. Komaki, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.

Joe Y. Chang, R. Mohan, J. Ajani, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Joe Y. Chang, J. Ajani, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer.

P. Thall, M. Mehta, M. Suntharalingam, 2017, Radiotherapy and Oncology.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Hedgehog: an Attribute to Tumor Regrowth after Chemoradiotherapy and a Target to Improve Radiation Response

J. Ajani, Tsung-Teh Wu, R. Komaki, 2006, Clinical Cancer Research.

Immune and circulating tumor DNA profiling following radiation treatment for oligometastatic NSCLC; translational correlatives from a mature randomized phase II trial.

X. Yi, S. Swisher, J. Wargo, 2020, International journal of radiation oncology, biology, physics.

Analysis of prognostic factors for T(1)N(0)M(0) glottic cancer treated with definitive radiotherapy alone: experience of the cancer hospital of Peking Union Medical College and the Chinese Academy Of Medical Sciences.

Z. Liao, J. Jin, Xiao-dong Huang, 2002, International journal of radiation oncology, biology, physics.

The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer.

Joe Y. Chang, L. Broemeling, Z. Liao, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters.

R. Mohan, J. Ajani, J. Roth, 2003, International journal of radiation oncology, biology, physics.

Coronary artery calcium score on standard of care oncologic CT scans for the prediction of adverse cardiovascular events in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy

R. Mohan, Xiaodong Zhang, T. Pan, 2022, Frontiers in Cardiovascular Medicine.

Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer

Steven H. Lin, R. Komaki, Z. Liao, 2016, American journal of clinical oncology.

Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging.

T. Bortfeld, R. Mohan, A. Niemierko, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma

Steven H. Lin, R. Komaki, Z. Liao, 2015, BMC Cancer.

Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response

J. Ajani, J. Roth, S. Swisher, 2005, Cancer.

Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.

C. Cleeland, T. Mendoza, Z. Liao, 2011, The oncologist.

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy

Q. Wei, D. Gomez, R. Komaki, 2011, BMC Cancer.

Associations between Single-Nucleotide Polymorphisms in the PI3K–PTEN–AKT–mTOR Pathway and Increased Risk of Brain Metastasis in Patients with Non–Small Cell Lung Cancer

Z. Liao, J. Zhao, Xianglin Yuan, 2013, Clinical Cancer Research.

Genetic Variants in Inflammation-Related Genes Are Associated with Radiation-Induced Toxicity Following Treatment for Non-Small Cell Lung Cancer

Joe Y. Chang, M. Spitz, J. Minna, 2010, PloS one.

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy

Q. Wei, R. Komaki, Z. Liao, 2013, PloS one.

Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy.

Joe Y. Chang, M. Spitz, Xifeng Wu, 2005, Seminars in oncology.

The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.

R. Mohan, Steven H. Lin, A. Koong, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial

R. Mohan, J. Lee, Z. Liao, 2020, Advances in radiation oncology.

A research protocol for a pilot randomized controlled trial designed to examine the feasibility of a couple-based mind-body intervention for patients with metastatic lung cancer and their partners

E. Bruera, Z. Liao, A. Tsao, 2018, Pilot and Feasibility Studies.

Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I--correlating internal lung motion with skin fiducial motion.

George Starkschall, Zhongxing Liao, Craig W Stevens, 2004, International journal of radiation oncology, biology, physics.

Changes in Pulmonary Function after Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, or Proton Beam Therapy for Non-Small Cell Lung Cancer

R. Mohan, D. Gomez, Z. Liao, 2014 .

Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.

R. Mohan, D. Gomez, R. Komaki, 2012, International journal of radiation oncology, biology, physics.

Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.

R. Mohan, Z. Liao, N. Choi, 2019, International journal of radiation oncology, biology, physics.

Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus.

Z. Liao, Jianji Pan, Xiong-wei Zheng, 2010, The Annals of thoracic surgery.

Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer.

Jinzhong Yang, J. Welsh, R. Komaki, 2011, International journal of radiation oncology, biology, physics.

Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus

J. Ajani, J. Roth, S. Swisher, 2005, Cancer.

Depressive symptoms and positive affect in Chinese and United States breast cancer survivors: a cross-cultural comparison

J. McQuade, Z. Liao, H. Nagendra, 2017, Supportive Care in Cancer.

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy

C. Cleeland, Z. Liao, R. Komaki, 2010, Brain, Behavior, and Immunity.

Atlas ranking and selection for automatic segmentation of the esophagus from CT scans

Jinzhong Yang, Peter Balter, Laurence Court, 2017, Physics in medicine and biology.

Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiotherapy.

Laurence Court, Lei Dong, Yongbin Zhang, 2013, Practical radiation oncology.

A deformable-model approach to semi-automatic segmentation of CT images demonstrated by application to the spinal canal.

Zhongxing Liao, Craig W Stevens, Stuart S C Burnett, 2004, Medical physics.

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Joe Y. Chang, Zhongxing Liao, James D. Cox, 2011, Front. Oncol..

Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.

R. Mohan, R. Komaki, Z. Liao, 2008, International journal of radiation oncology, biology, physics.

Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer

P. A. Futreal, X. Yi, I. Wistuba, 2019, Nature Communications.

Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy

C. Cleeland, Z. Liao, L. Mao, 2012, Brain, Behavior, and Immunity.

Incidental receipt of cardiac medications and survival outcomes among patients with stage III non-small-cell lung cancer after definitive radiotherapy.

D. Gomez, Y. Liu, Z. Liao, 2015, Clinical lung cancer.

Dyadic yoga program for patients undergoing thoracic radiotherapy and their family caregivers: Results of a pilot randomized controlled trial

E. Bruera, Z. Liao, R. Nagarathna, 2019, Psycho-oncology.

Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms.

Joe Y. Chang, C. Cleeland, D. Fairclough, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

THE MANAGEMENT OF SUPERIOR SULCUS TUMORS

W. Hong, J. Roth, C. Stevens, 2001 .

Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.

Joe Y. Chang, T. Guerrero, J. Ajani, 2005, International journal of radiation oncology, biology, physics.

Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.

P. Thall, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Heterogeneous planning for homogeneous protocols.

K. Forster, G. Starkschall, C. Stevens, 2004, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Lung Size and the Risk of Radiation Pneumonitis.

M. Martel, Z. Liao, S. Krafft, 2016, International journal of radiation oncology, biology, physics.

Factors Associated With Severe Pneumonitis for Limited Stage Small Cell Lung Cancer

R. Mohan, E. Holliday, Steven H. Lin, 2015 .

Comparing Risk Of Radiation Pneumonitis After Intensity-modulated Radiotherapy Vs. Proton Therapy

R. Mohan, Z. Liao, S. Tucker, 2014 .

Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Radhe Mohan, Zhongxing Liao, Sue S Yom, 2007, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.

Karl Prado, Zhongxing Liao, Craig W Stevens, 2005, International journal of radiation oncology, biology, physics.

Qigong improves quality of life in women undergoing radiotherapy for breast cancer

C. Kirschbaum, J. McQuade, Z. Liao, 2013, Cancer.

Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung.

Z. Liao, S. Tucker, E. Travis, 1995, International journal of radiation oncology, biology, physics.

Status of particle therapy for lung cancer

Steven H. Lin, Z. Liao, J. Cox, 2011, Acta oncologica.

Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer

Joe Y. Chang, R. Komaki, Z. Liao, 2011, Cancer.

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study

Joe Y. Chang, J. Welsh, Steven H. Lin, 2021, Clinical and translational radiation oncology.

Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiotherapy-Induced Cardiotoxicity in Non-Small Cell Lung Cancer Patients: A Secondary Analysis of a Prospective Randomized Trial.

R. Mohan, Steven H. Lin, Z. Liao, 2021, International journal of radiation oncology, biology, physics.

Log odds of positive lymph nodes may predict survival benefit in patients with node-positive non-small cell lung cancer.

Z. Liao, Pei Yang, W. Deng, 2018, Lung cancer.

Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.

W. Hong, R. Herbst, R. Komaki, 2009, International journal of radiation oncology, biology, physics.

The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.

Steven H. Lin, R. Komaki, Z. Liao, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non–small cell lung cancer after concurrent chemoradiation

K. Hess, Steven H. Lin, Z. Liao, 2020, Science Advances.

A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.

M. Mehta, Steven H. Lin, N. Bhooshan, 2017, International journal of radiation oncology, biology, physics.

A Multi-institutional Analysis of Radiation Dosimetric Predictors of Toxicity Following Trimodality Therapy for Esophageal Cancer.

Steven H. Lin, Z. Liao, W. Harmsen, 2021, Practical radiation oncology.

Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleural mesothelioma.

Z. Liao, A. Chi, N. Nguyen, 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.

Z. Liao, H. Thames, L. Milas, 2013, International journal of radiation oncology, biology, physics.

Unilateral nephrectomy 24 hours after bilateral kidney irradiation reduces damage to the function and structure of the remaining kidney.

Z. Liao, E. Travis, 1994, Radiation research.

HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.

R. Mohan, Q. Wei, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy.

Q. Wei, D. Gomez, Z. Liao, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Investigation of the relationship between gross tumor volume location and pneumonitis rates using a large clinical database of non-small-cell lung cancer patients.

Zhongxing Liao, Yevgeniy Vinogradskiy, M. Martel, 2012, International journal of radiation oncology, biology, physics.

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005, Clinical Cancer Research.

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases

R. Komaki, Z. Liao, J. Welsh, 2012, PloS one.

Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer

Bradley J. Barney, V. Johnson, C. Cleeland, 2013, Quality of Life Research.

T-Cell Receptor Profiling and Prognosis After Stereotactic Body Radiation Therapy For Stage I Non-Small-Cell Lung Cancer

Z. Liao, J. Welsh, Xuan Pan, 2021, Frontiers in Immunology.

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer

D. Gomez, R. Komaki, Z. Liao, 2018, Cancer medicine.

PET/CT Fusion with Treatment Planning CT (TP CT) Shows Predominant Pattern of Locoregional Failure in Esophageal Patients Treated with Chemoradiation (CRT) is in GTV

T. Guerrero, M. McAleer, M. Bucci, 2008 .

Reducing the toxicity of cancer therapy: recognizing needs, taking action

Zhongxing Liao, C. Cleeland, Z. Liao, 2012, Nature Reviews Clinical Oncology.

Large Decreases in Standardized Uptake Values After Definitive Radiation Are Associated with Better Survival of Patients with Locally Advanced Non–Small Cell Lung Cancer

G. Gladish, D. Gomez, R. Komaki, 2012, The Journal of Nuclear Medicine.

Associations between Spirituality, Mindfulness, and Psychological Symptoms among Advanced Lung Cancer Patients and Their Spousal Caregivers.

Z. Liao, K. Milbury, D. Cho, 2020, Journal of pain and symptom management.

Pilot Testing of a Brief Couple-Based Mind-Body Intervention for Patients With Metastatic Non-Small Cell Lung Cancer and Their Partners.

E. Bruera, Z. Liao, A. Tsao, 2017, Journal of pain and symptom management.

Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer

K. Hess, Z. Liao, Chad Tang, 2017, Clinical & Experimental Metastasis.

Fixed- versus Variable-RBE Computations for Intensity Modulated Proton Therapy

R. Mohan, Z. Liao, P. Yepes, 2018, Advances in radiation oncology.

Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.

R. Mohan, R. Komaki, Z. Liao, 2006, International journal of radiation oncology, biology, physics.

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Steven H. Lin, R. Komaki, Z. Liao, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.

Radhe Mohan, Lei Dong, Zhongxing Liao, 2004, International journal of radiation oncology, biology, physics.

APhase IClinicalTrial ofThoracic Radiotherapy and Concurrent Celecoxib for Patientswith Unfavorable Performance Status Inoperable/Unresectable Non^Small Cell Lung Cancer

Joe Y. Chang, Z. Liao, J. Cox, 2005 .

Update: Modern Approaches to the Treatment of Localized Esophageal Cancer

J. Ajani, D. Gomez, R. Komaki, 2011, Current oncology reports.

Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.

R. Mohan, M. Martel, Jinzhong Yang, 2016, International journal of radiation oncology, biology, physics.

Clinical implementation of intensity modulated proton therapy for thoracic malignancies.

Heng Li, Joe Y. Chang, Zhongxing Liao, 2014, International journal of radiation oncology, biology, physics.

Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung.

Z. Liao, S. Tucker, E. Travis, 1997, International journal of radiation oncology, biology, physics.

Monitoring PD-L1 Expression on Circulating Tumor–Associated Cells in Recurrent Metastatic Non–Small-Cell Lung Carcinoma Predicts Response to Immunotherapy With Radiation Therapy

Steven H. Lin, Z. Liao, M. Edelman, 2022, JCO precision oncology.

Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation.

Joe Y. Chang, P. Balter, R. Komaki, 2010, International journal of radiation oncology, biology, physics.

Evaluation of the systematic error in using 3D dose calculation in scanning beam proton therapy for lung cancer

Joe Y. Chang, Xiaodong Zhang, Z. Liao, 2014, Journal of applied clinical medical physics.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

Joe Y. Chang, D. Gomez, R. Komaki, 2014, International journal of radiation oncology, biology, physics.

A Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials

R. Mohan, M. Martel, Jinzhong Yang, 2017, Scientific Reports.

(18)F-Fluorodeoxyglucose Positron Emission Tomography Can Quantify and Predict Esophageal Injury During Radiation Therapy.

R. Mohan, M. Martel, Jinzhong Yang, 2016, International journal of radiation oncology, biology, physics.

DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer

Q. Wei, L. Court, D. Gomez, 2018, Chronic diseases and translational medicine.

Differences in quality of life between American and Chinese breast cancer survivors

J. McQuade, Q. Lu, Z. Liao, 2016, Supportive Care in Cancer.

Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?

Radhe Mohan, Joe Y. Chang, Zhongxing Liao, 2012, International journal of radiation oncology, biology, physics.

Proton beam therapy and concurrent chemotherapy for esophageal cancer.

R. Mohan, J. Ajani, S. Swisher, 2012, International journal of radiation oncology, biology, physics.

Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer.

Radhe Mohan, Zhongxing Liao, Wayne D Newhauser, 2008, International journal of radiation oncology, biology, physics.

Comparison of Locoregional versus Extended Locoregional Radiation Volumes for Patients with Nonmetastatic Gastro-esophageal Junction Carcinomas

P. Thall, Steven H. Lin, R. Komaki, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.

R. Mohan, D. Gomez, R. Komaki, 2012, International journal of radiation oncology, biology, physics.

A Mindfulness-Based Intervention as a Supportive Care Strategy for Patients with Metastatic Non-Small Cell Lung Cancer and their Spouses: Results of a 3-Arm Pilot Randomized Controlled Trial.

E. Bruera, Z. Liao, A. Tsao, 2020, The oncologist.

Geometric and dosimetric accuracy of deformable image registration between average‐intensity images for 4DCT‐based adaptive radiotherapy for non‐small cell lung cancer

R. Mohan, K. Brock, P. Balter, 2021, Journal of applied clinical medical physics.

Couple-based mind-body intervention for patients with metastatic lung cancer and their spouses.

E. Bruera, Z. Liao, A. Tsao, 2017 .

On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients.

R. Mohan, Z. Liao, S. Monti, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy.

R. Mohan, R. Komaki, Z. Liao, 2006, International journal of radiation oncology, biology, physics.

Reduced Incidence of Severe Acute Toxicities in Esophageal Cancer Treated with Proton Therapy

D. Gomez, Steven H. Lin, R. Komaki, 2015 .

Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era.

J. Ajani, R. Komaki, Z. Liao, 2012, International journal of radiation oncology, biology, physics.

Outcomes with Esophageal Cancer Radiation Therapy

Joe Y. Chang, J. Ajani, S. Swisher, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

What Would Be the Most Appropriate α/β Ratio in the Setting of Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer

Zhongxing Liao, Sijin Wen, Nam P. Nguyen, 2013, BioMed research international.

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

Joe Y. Chang, Lei Dong, Zhongxing Liao, 2008, International journal of radiation oncology, biology, physics.

Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.

Wei Liu, Radhe Mohan, Heng Li, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dosimetric benefits of respiratory gating: a preliminary study

George Starkschall, Zhongxing Liao, Charles Bloch, 2004, Journal of applied clinical medical physics.

Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.

R. Mohan, M. Martel, Z. Liao, 2013, International journal of radiation oncology, biology, physics.

Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer.

Wei Liu, Joe Y. Chang, Martin Bues, 2018, International journal of radiation oncology, biology, physics.

Impact of respiratory motion on worst-case scenario optimized intensity modulated proton therapy for lung cancers.

Wei Liu, Radhe Mohan, Heng Li, 2015, Practical radiation oncology.

Effects of respiratory motion on passively scattered proton therapy versus intensity modulated photon therapy for stage III lung cancer: are proton plans more sensitive to breathing motion?

R. Mohan, L. Court, Z. Liao, 2013, International journal of radiation oncology, biology, physics.

Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.

Joe Y. Chang, R. Mohan, D. Gomez, 2016, Journal of pain and symptom management.

Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus

J. Ajani, S. Swisher, Z. Liao, 2008, Cancer.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Joe Y. Chang, T. Guerrero, J. Ajani, 2004, International journal of radiation oncology, biology, physics.

Postoperative Hemithoracic Intensity Modulated Radiation Therapy (IMRT) With an Optional Integrated Boost for Malignant Pleural Mesothelioma: Toxicity, Patterns of Failure, and a Matched Survival Analysis

D. Gomez, Z. Liao, J. Welsh, 2014 .

Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645).

Helen H Liu, R. Komaki, Z. Liao, 2006, International journal of radiation oncology, biology, physics.

111: V20 Predicts Fatal Pulmonary Toxicity After Extrapleural Pneumonectomy and Intensity Modulated Radiation Therapy

T. Guerrero, K. Forster, C. Stevens, 2006 .

2472 : The Volume of Lung Receiving low Radiation Doses Is Associated With Treatment Related Lung Toxicity When Irradiating Tumors in the Thorax

R. Mohan, Hanli Liu, R. Komaki, 2006 .

Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer

K. Hess, Z. Liao, Chad Tang, 2017, Clinical and Experimental Metastasis.

Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy.

D. Gomez, Z. Liao, J. Huo, 2017, International Journal of Radiation Oncology, Biology, Physics.

Evaluation of Lung IMRT Plans Quality Using a Knowledge-Based Engineering Tool

R. Mohan, Qiuwen Wu, J. Galvin, 2015 .

Predictive Models for Assuring Quality and Consistency of Lung IMRT Plans Across Institutions in Cooperative Group Trials

R. Mohan, Qiuwen Wu, J. Galvin, 2014 .

Severe Radiation Induced Dermatitis after IMRT or Proton Therapy for Thoracic Cancer Patients

R. Mohan, M. Durante, Z. Liao, 2019, International Journal of Radiation Oncology*Biology*Physics.

Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non–Small Cell Lung Cancer

D. Gomez, R. Komaki, Z. Liao, 2017, American journal of clinical oncology.

Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer

K. Hess, D. Gomez, R. Komaki, 2016, Acta oncologica.

A Multi-institutional Analysis of Acute Toxicity After Neoadjuvant Chemoradiation Using Photons or Protons in Trimodality Esophageal Cancer Patients

M. Mehta, M. Suntharalingam, N. Bhooshan, 2015 .

Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer.

Ash A. Alizadeh, A. Newman, J. Chabon, 2017 .

Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.

Heng Li, Li Liao, Joe Y. Chang, 2014, Practical radiation oncology.

On the interplay effects with proton scanning beams in stage III lung cancer.

Heng Li, Li Liao, Joe Y. Chang, 2014, Medical physics.

Interactively exploring optimized treatment plans.

Zhongxing Liao, H Helen Liu, I. Rosen, 2005, International journal of radiation oncology, biology, physics.

Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.

Z. Liao, P. Mclaughlin, J. Manning, 2000, International journal of radiation oncology, biology, physics.

Malt (mucosa associated lymphoid tissue) lymphoma with supradiaphragmatic presentation: Natural history and patterns of failure

Z. Liao, P. Mclaughlin, J. Manning, 1998 .

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer

T. Pan, D. Gomez, R. Komaki, 2017, Clinical and translational radiation oncology.

Impact of using different four-dimensional computed tomography data sets to design proton treatment plans for distal esophageal cancer.

R. Mohan, Xiaodong Zhang, Z. Liao, 2009, International journal of radiation oncology, biology, physics.

Reirradiation of Thoracic Cancers with Intensity Modulated Proton Therapy.

D. Gomez, X. Zhu, R. Komaki, 2017, International journal of radiation oncology, biology, physics.

Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study

S. Swisher, Steven H. Lin, R. Komaki, 2017, Advances in radiation oncology.

Potential for Improvements in Robustness and Optimality of Intensity-Modulated Proton Therapy for Lung Cancer with 4-Dimensional Robust Optimization

Shuaiping Ge, Xiaochun Wang, Zhongxing Liao, 2019, Cancers.

IMRT reduces lung irradiation in distal esophageal cancer over 3D CRT

T. Guerrero, R. Mohan, C. Stevens, 2003 .

Proposed modification of nodal status in AJCC esophageal cancer staging system.

J. Ajani, J. Roth, S. Swisher, 2007, The Annals of thoracic surgery.

Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer.

Radhe Mohan, Daniel Gomez, James D. Cox, 2016 .

Integrated circulating tumor DNA and T cell repertoire predict radiotherapeutic response and outcome in non‐small cell lung cancer patients with brain metastasis

Z. Liao, Zelong Xu, F. Tong, 2023, Cancer Communications.

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

R. Mohan, M. Martel, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

In Reply to Jin et al.

M. Martel, Z. Liao, S. Krafft, 2016, International journal of radiation oncology, biology, physics.

Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort

R. Mohan, M. Martel, Z. Liao, 2014, Acta oncologica.

A novel method to incorporate the spatial location of the lung dose distribution into predictive radiation pneumonitis modeling.

M. Martel, Z. Liao, S. Tucker, 2012, International journal of radiation oncology, biology, physics.

Accuracy of two heterogeneity dose calculation algorithms for IMRT in treatment plans designed using an anthropomorphic thorax phantom.

Lei Dong, Zhongxing Liao, David S Followill, 2007, Medical physics.

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

Joe Y. Chang, I. Wistuba, S. Swisher, 2023, The Lancet.

Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy.

Joe Y. Chang, Jian Sun, Xiaodong Zhang, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

J. Ajani, S. Swisher, Steven H. Lin, 2013, International journal of radiation oncology, biology, physics.

Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer

P. Thall, R. Mohan, J. Ajani, 2019, International Journal of Radiation Oncology*Biology*Physics.

Novel Hybrid Scattering- and Scanning-Beam Proton Therapy Approach.

Joe Y. Chang, Jian Sun, Xiaodong Zhang, 2016, International journal of particle therapy.

Patient-specific quantification of respiratory motion-induced dose uncertainty for step-and-shoot IMRT of lung cancer.

Xiaodong Zhang, P. Balter, X. Zhu, 2013, Medical physics.

Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part II-margin reduction of internal target volume.

George Starkschall, Zhongxing Liao, Craig W Stevens, 2004, International journal of radiation oncology, biology, physics.

PD4-1-6: Acute esophageal reactions from proton beam therapy and concurrent chemotherapy for non-small cell lung cancer (NSCLS): Reduction in incidence and severity despite higher doses

Joe Y. Chang, M. McAleer, M. Bucci, 2007 .

Optimization of mesh generation for geometric accuracy, robustness, and efficiency of biomechanical model-based deformable image registration.

R. Mohan, K. Brock, P. Balter, 2022, Medical physics.

Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung.

Z. Liao, S. Tucker, E. Travis, 1997, International journal of radiation oncology, biology, physics.

Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer.

Joe Y. Chang, S. Shirvani, D. Gomez, 2013, International journal of radiation oncology, biology, physics.

Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer.

M. Martel, D. Gomez, R. Komaki, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.

Ash A. Alizadeh, K. Ramchandran, J. Chabon, 2020 .

Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes

Ash A. Alizadeh, K. Ramchandran, J. Chabon, 2019, International Journal of Radiation Oncology, Biology, Physics.

Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.

R. Mohan, M. Martel, R. Komaki, 2010, International journal of radiation oncology, biology, physics.

O-71 Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) increased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy

R. Herbst, C. Stevens, R. Komaki, 2003 .

International outreach: what is the responsibility of ASTRO and the major international radiation oncology societies?

Z. Liao, J. Palta, N. Mayr, 2014, International journal of radiation oncology, biology, physics.

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

D. Gomez, Z. Liao, L. Levy, 2017, Translational oncology.

Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non – Small Cell Lung Cancer ( NSCLC ) Receiving

Z. Liao, L. Levy, Yipeng Song, 2017 .

Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.

S. Swisher, R. Komaki, Z. Liao, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Radiotherapy in malignant pleural mesothelioma.

M. McAleer, Z. Liao, A. Tsao, 2009, International journal of radiation oncology, biology, physics.

Early Results of Stereotactic Body Radiation Therapy (SBRT) in Centrally/Superiorly Located Stage I or Isolated Recurrent NSCLC

P. Balter, M. McAleer, M. Bucci, 2008 .

Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.

R. Mohan, M. Martel, D. Gomez, 2012, International journal of radiation oncology, biology, physics.

Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.

Thomas Guerrero, Radhe Mohan, Zhongxing Liao, 2007, International journal of radiation oncology, biology, physics.

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

R. Mohan, M. Martel, R. Komaki, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation‐induced esophagitis

Laurence E. Court, Daniel Gomez, Lei Dong, 2013, Journal of applied clinical medical physics.

Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer.

Hongliang Liu, D. Gomez, J. Welsh, 2016, Clinical lung cancer.

Pulmonary Function Tests Before and After Stereotactic Radiation of the Lung

T. Guerrero, P. Balter, M. McAleer, 2007 .

Attenuation correction of PET cardiac data with low-dose average CT in PET/CT.

Tinsu Pan, Osama Mawlawi, Zhongxing Liao, 2006, Medical physics.

Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.

Joe Y. Chang, J. Ajani, S. Swisher, 2014, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity after irradiation for non–small-cell lung cancer

D. Gomez, Z. Liao, Q. Nguyen, 2018, Chronic diseases and translational medicine.